|
|
Volumn 23, Issue 7 SUPPL., 2000, Pages
|
|
The anti-ischemic potential of angiotensin:converting enzyme inhibition: Insights from the heart outcomes prevention evaluation trial
|
|
Author keywords
Angiotensin converting enzyme inhibitors; Congestive heart failure; Diabetes; Ischemia; Left ventricular dysfunction; Ramipril; Stroke
|
|
Indexed keywords
ALPHA TOCOPHEROL;
AMLODIPINE;
ANGIOTENSIN;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BRADYKININ;
CALCIUM ANTAGONIST;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
CELL ADHESION MOLECULE;
CHOLESTEROL;
CYTOKINE;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
FOSINOPRIL;
GROWTH FACTOR;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
LIPID;
LISINOPRIL;
NISOLDIPINE;
RAMIPRIL;
RENIN;
TRANDOLAPRIL;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VASODILATOR AGENT;
ZOFENDOPRIL;
ARTICLE;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
HYPERTENSION;
NONHUMAN;
|
|
EID: 0033939506
PISSN: 01609289
EISSN: None
Source Type: Journal
DOI: 10.1002/clc.4960230704 Document Type: Article |
|
Times cited : (21)
|
|
References (21)
|
